Rosario LoBrutto
Head of Scientific Affairs
Sandoz
Rosario has 25+ years’ experience as an inspiring, patient-centric leader in the industry driving R&D with a strong focus on regulatory strategy, commercial, and operational excellence in development, scale-up and launch preparation of generic/branded products at Merck, Novartis, TEVA and Sandoz. This includes development of APIs/drug products containing small molecules, synthetic polypeptides and proteins and drug-device combination products. Currently at Sandoz he is Head of Scientific Affairs responsible for external partnership product development and oversees due diligence evaluating CMC/bio-analytical aspects of new product opportunities amenable to co-development, in-licensing or acquisition. Moreover, he advances pipeline strategy and pioneering access for patients leading team in the identification, evaluation and prioritization of internal/external assets.